NCT05093231
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05093231
Title Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cambridge University Hospitals NHS Foundation Trust
Indications
Therapies
Age Groups: senior | adult
Covered Countries GBR

Facility Status City State Zip Country Details
Addenbrooke's Hospital RECRUITING Cambridge Cambridgeshire CB2 0QQ United Kingdom Details
Velindre Cancer Centre RECRUITING Cardiff CF14 2TL United Kingdom Details
University Hospitals Coventry and Warwickshire RECRUITING Coventry United Kingdom Details
Beatson West of Scotland Cancer Centre RECRUITING Glasgow United Kingdom Details
St James' University Hospital RECRUITING Leeds United Kingdom Details
Guy's and St Thomas' NHS Foundation Trust RECRUITING London United Kingdom Details
Royal Free Hospital RECRUITING London United Kingdom Details
University College London Hospitals NHS Foundation Trust RECRUITING London United Kingdom Details
The Christie RECRUITING Manchester United Kingdom Details
Milton Keynes University Hospital RECRUITING Milton Keynes United Kingdom Details
Norfolk and Norwich University Hospital RECRUITING Norwich United Kingdom Details
Nottingham University Hospitals NHS Foundation Trust RECRUITING Nottingham United Kingdom Details
Derriford Hospital RECRUITING Plymouth United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field